Cargando…
Experience with procalcitonin use during the COVID-19 pandemic
Autores principales: | Gonzalez, Laura, Holman, Thomas, Wait, Daniel, Abenojar, Pearl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008189/ https://www.ncbi.nlm.nih.gov/pubmed/35465971 http://dx.doi.org/10.1016/j.ejim.2022.04.002 |
Ejemplares similares
-
Pathogenetic Mechanism of Procalcitonin in COVID-19
por: Wiedermann, Franz J
Publicado: (2021) -
Single-centre experience of using procalcitonin to guide antibiotic therapy in COVID-19 intensive care patients
por: Moseley, P., et al.
Publicado: (2022) -
Psychotic experiences in student population during the COVID-19 pandemic
por: Hajdúk, Michal, et al.
Publicado: (2020) -
Serum procalcitonin in sepsis
por: Wiwanitkit, Viroj
Publicado: (2011) -
The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)